Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
210.01
+3.47 (1.68%)
At close: Dec 11, 2025, 4:00 PM EST
210.46
+0.45 (0.21%)
After-hours: Dec 11, 2025, 7:59 PM EST

Johnson & Johnson Revenue

Johnson & Johnson had revenue of $23.99B in the quarter ending September 28, 2025, with 6.77% growth. This brings the company's revenue in the last twelve months to $92.15B, up 5.08% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.

Revenue (ttm)
$92.15B
Revenue Growth
+5.08%
P/S Ratio
5.49
Revenue / Employee
$667,263
Employees
138,100
Market Cap
505.98B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 29, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 201982.06B478.00M0.59%
Dec 30, 201881.58B5.13B6.71%
Dec 31, 201776.45B4.56B6.34%
Jan 1, 201771.89B1.82B2.59%
Jan 3, 201670.07B-4.26B-5.73%
Dec 28, 201474.33B--
Dec 29, 2013---
Dec 30, 201267.22B2.19B3.37%
Jan 1, 201265.03B3.44B5.59%
Jan 2, 201161.59B-310.00M-0.50%
Jan 3, 201061.90B-1.85B-2.90%
Dec 28, 200863.75B2.65B4.34%
Dec 30, 200761.10B7.77B14.57%
Dec 31, 200653.32B-7.77B-12.72%
Jan 1, 200661.10B7.77B14.57%
Jan 2, 200553.32B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Abbott Laboratories43.84B
Revenue Rankings